Literature DB >> 137937

A reevaluation of fatty acids as inflammatory agents in acne.

S M Puhvel, M Sakamoto.   

Abstract

The currently widely held theory that intrafollicular free fatty acids (FA) are the primary agents instigating inflammatory changes in acne is based on circumstantial evidence. There is no direct evidence that FA in physiologic concentrations are inflammatory. In the present study the quantities of FA present in isolated pilosebaceous ducts and in isolated comedones were analyzed. Using these values, the effect of FA on intracutaneous injection into human skin was investigated. The range of FA in 257 isolated pilosebaceous ducts from skin of the upper back of 10 male subjects was 0.19 to 2.43 mug, with an average of 0.89 +/- 0.75 mug of FA per duct. The mean FA content in 45 open comedones was 63.6 +/- 24.8 mug per comedone. Fatty acids for intracutaneous testing were isolated from human skin surface lipids and from hydrolyzed triglycerides purified from pooled isolated sebaceous glands. Twenty-six subjects received 100 mug of FA intracutaneously in the upper back. The response to FA injections could not be distinguished from the response to saline control injections. By 24 hr no erythema, induration, or any visible marks of inflammation were present in the skin of any of the subjects tested. At the histologic level a mild inflammatory infiltrate consisting perdominantly of lymphocytes was slightly more marked in the FA injection site than in the saline control injection site. Increasing the amount of FA injected to 500 mug still produced no visible inflammatory response in human skin. We conclude that intracutaneous injections of FA in physiologic concentrations do not produce more than a very mild inflammatory reaction in human skin and suggest that the role of Propionibacterium acnes in the pathogeneisis of acne may be more complex than merely as a source of intrafollicular lipases.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 137937     DOI: 10.1111/1523-1747.ep12491639

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  [Porphyrinsynthesis of Propionibacterium acnes in acne and seborrhea (author's transl)].

Authors:  D Fanta; I Formanek; C Poitschek; J Thurner
Journal:  Arch Dermatol Res       Date:  1978-04-07       Impact factor: 3.017

2.  Dermatology-epitomes of progress: new concepts in pathogenesis of acne.

Authors:  S M Puhvel
Journal:  West J Med       Date:  1979-02

Review 3.  Immunology of diseases associated with Malassezia species.

Authors:  H Ruth Ashbee; E Glyn V Evans
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

4.  The inhibition of free radical generation by human neutrophils through the synergistic effects of metronidazole with palmitoleic acid: a possible mechanism of action of metronidazole in rosacea and acne.

Authors:  H Akamatsu; M Oguchi; S Nishijima; Y Asada; M Takahashi; T Ushijima; Y Niwa
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

5.  Inflammation due to intra-cutaneous implantation of stratum corneum.

Authors:  K Dalziel; P J Dykes; R Marks
Journal:  Br J Exp Pathol       Date:  1984-02

6.  Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris.

Authors:  Teruaki Nakatsuji; Mandy C Kao; Jia-You Fang; Christos C Zouboulis; Liangfang Zhang; Richard L Gallo; Chun-Ming Huang
Journal:  J Invest Dermatol       Date:  2009-04-23       Impact factor: 8.551

7.  Prostaglandin-like substances in Propionibacterium acnes. III. Differential contractile effects on smooth muscle layers of the human utero-tubal junction.

Authors:  L Hellgren; B Lindblom; J Vincent; L Wilhelmsson
Journal:  Experientia       Date:  1979-10-15

8.  Chemotactic efficiency of various chemoattractants for polymorphonuclear leukocytes in inflammatory acne vulgaris.

Authors:  J Knop; T Bossecker; P M Kövary
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.